A phase II trial of concurrent radiochemotherapy with carboplatin (CBDCA) and weekly docetaxel (TXT) in locally advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Suzuki, R [1 ]
Taniguchi, H [1 ]
Kondoh, Y [1 ]
Shindoh, J [1 ]
Matsumoto, S [1 ]
Hiramatsu, T [1 ]
Gonda, H [1 ]
Baba, K [1 ]
Hasegawa, Y [1 ]
Shimokata, K [1 ]
机构：
[1] Cent Japan Lung Study Grp, Nagoya, Aichi, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7174
引用
收藏
页码：659S / 659S
页数：1
相关论文
共 50 条
  • [1] WEEKLY DOCETAXEL AND CARBOPLATIN WITH CONCURRENT RADIATION THERAPY FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Tanikawa, Y.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 123 - 123
  • [2] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)
    Sovak, M. A.
    Lutzker, S.
    Guensch, L.
    Joyce, M.
    Schwartz, S.
    Wu, Y.
    Zheng, L.
    Aisner, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] A Phase II Study of Concurrent Chemoradiation with Weekly Docetaxel, Carboplatin, and Radiation Therapy Followed by Consolidation Chemotherapy with Docetaxel and Carboplatin for Locally Advanced Inoperable Non-small Cell Lung Cancer (NSCLC)
    Jain, Anshu K.
    Hughes, Randall S.
    Sandler, Alan B.
    Dowlati, Afshin
    Schwartzberg, Lee S.
    Dobbs, Tracy
    Schlabach, Larry
    Wu, Jean
    Muldowney, Nancy J.
    Choy, Hak
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (06) : 722 - 727
  • [4] A phase II study of carboplatin and weekly docetaxel in advanced non-small cell lung cancer
    Moore, T
    Patel, T
    Segal, M
    Thompson, J
    Zangmeister, J
    Larrimer, N
    Merriman, N
    Chidiac, T
    [J]. LUNG CANCER, 2005, 49 : S259 - S259
  • [5] Phase I/II trial of docetaxel (D) and Carboplatin (CBDCA) as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Giannakakis, T
    Papadouris, S
    Kourousis, C
    Kalbakis, NK
    Tzianni, V
    Lidaki, E
    Androulakis, N
    Souklakos, J
    Sarra, E
    Georgoulias, V
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 94 - 94
  • [6] A phase II trial of weekly paclitaxel and carboplatin for elderly patients with advanced non-small cell lung cancer (NSCLC).
    Usui, K
    Inoue, A
    Ishimoto, O
    Tanaka, M
    Koinumaru, S
    Matsubara, N
    Kanbe, M
    Gomi, K
    Saijo, Y
    Nukiwa, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 682S - 682S
  • [7] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)-Final report
    Sovak, M. A.
    Guensch, L.
    Joyce, P.
    Lutzker, S. G.
    Schwartz, S.
    Shih, W. J.
    Zheng, L.
    Aisner, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Combination chemotherapy with carboplatin(CBDCA), docetaxel (DOC) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC). A phase II study
    Pectasides, D
    Aspropotamitis, A
    Halikia, A
    Visvikis, A
    Antoniou, F
    Kalantaridou, A
    Batzios, S
    Karvounis, N
    Athanassiou, A
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S263 - S263
  • [9] Phase II trial of docetaxel and carboplatin in the treatment of advanced non-small cell lung cancer
    Schutte, W
    Bork, I
    Wollschlager, B
    Schadlich, S
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1076 - 1076
  • [10] Phase II trial of weekly docetaxel and carboplatin as first line chemotherapy in advanced or metastatic non small cell lung cancer (NSCLC).
    Chahine, GY
    Nasr, FL
    Kattan, JG
    Farhat, FS
    El Seoudi, ME
    Bachour, M
    Moukadem, WT
    Younes, FC
    Ghosn, MG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 702S - 702S
12345